Evaluation of safety,tolerability and immunogenicity of vaccination with Varivax (V210) in healthy Indian children

Trial Profile

Evaluation of safety,tolerability and immunogenicity of vaccination with Varivax (V210) in healthy Indian children

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Mar 2017

At a glance

  • Drugs Varicella zoster virus vaccine live (Primary)
  • Indications Varicella zoster virus infections
  • Focus Pharmacodynamics; Registrational
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 07 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top